Table 2. Univariable cox regression for atrial fibrillation recurrence (n=2293)
Variable Univariate Univariate
HR(95%CI) P-value
Age 1.003(0.995-1.011) 0.441
Female sex 1.305(1.106-1.540) 0.002
Persistent AF 1.116(0.945-1.318) 0.195
AF duration* 1.002(1.000-1.004) 0.055
Congestive heart failure 1.151(0.596-2.223) 0.676
Hypertension 1.024(0.870-1.206) 0.775
Diabetes mellitus 1.507(1.234-1.841) 0.000
Prior stroke/TIA /systemic embolism 1.007(0.762-1.329) 0.962
Vascular disease 1.109(0.912-1.348) 0.300
CHA2DS2-VASc score 1.061(1.008-1.116) 0.023
HAS-BLED score 0.902(0.794-1.026) 0.116
Alcohol consumption 0.879(0.718-1.075) 0.209
LAD ≥ 40 mm 1.373(1.166-1.616) 0.000
Observational period prescription
ACEI/ARB 1.197(0.992-1.444) 0.061
Statins 1.081(0.885-1.320) 0.444
Long-term prescription
ACEI/ARB 1.122(0.947-1.330) 0.183
Statins 1.079(0.909-1.281) 0.386
Obesity# 1.186(0.994-1.416) 0.059
Abbreviations: AF, atrial fibrillation; CHA2DS2-VASc, congestive heart failure, hypertension, age 75 years or older (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 years, sex category (female); HAS-BLED, hypertension, abnormal renal or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, drugs or alcohol concomitantly; LAD, left atrial diameter; ACEI, angiotensin converting enzyme inhibitors; ARB, Angiotensin receptor blockers. Abbreviations: AF, atrial fibrillation; CHA2DS2-VASc, congestive heart failure, hypertension, age 75 years or older (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 years, sex category (female); HAS-BLED, hypertension, abnormal renal or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, drugs or alcohol concomitantly; LAD, left atrial diameter; ACEI, angiotensin converting enzyme inhibitors; ARB, Angiotensin receptor blockers. Abbreviations: AF, atrial fibrillation; CHA2DS2-VASc, congestive heart failure, hypertension, age 75 years or older (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 years, sex category (female); HAS-BLED, hypertension, abnormal renal or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, drugs or alcohol concomitantly; LAD, left atrial diameter; ACEI, angiotensin converting enzyme inhibitors; ARB, Angiotensin receptor blockers.
since first diagnosis; # BMI ≥28.0 * since first diagnosis; # BMI ≥28.0